Table 1.
Outcome | Exposure | No. SNP | PIVW | PFDR | OR | 95% CI | Horizontal pleiotropy | Heterogeneity | |||
---|---|---|---|---|---|---|---|---|---|---|---|
Egger intercept | SE | P-value | Cochran’s Q | P-value | |||||||
JIA | CD3 on CM CD8br | 18 | 3.33e-05 | 0.024** | 0.731 | 0.63–0.848 | 0.028 | 0.035 | 0.437 | 13.447 | 0.706 |
HLA DR on CD14+ CD16- monocyte | 22 | 0.000683 | 0.168* | 0.748 | 0.633–0.885 | 0.012 | 0.052 | 0.821 | 40.645 | 0.006 | |
HLA DR on CD14+ monocyte | 21 | 0.00069 | 0.168* | 0.743 | 0.627–0.883 | 0.011 | 0.053 | 0.826 | 38.655 | 0.007 |
FDR, FDR, false negative discovery rate, Benjamini-Hochberg method was used for adjustment
SNP Single Nucleotide Polymorphism: OR odds ratio: CI confidence interval
*Indicates significant difference in PFDR at 0.2 level
**indicates significant difference in PFDR at 0.05 level